Sonoma Pharmaceuticals vs Jin Medical International
Sonoma Pharmaceuticals and Jin Medical International are similar in size: $19.5m and $20.7m of revenue in their latest fiscal years. Sonoma Pharmaceuticals grew faster (36.7% against -12.0%). Jin Medical International kept more of each dollar of sales as profit: a net margin of 5.8% against -16.3%.
| Latest fiscal year | Sonoma PharmaceuticalsSNOA, 2026 | Jin Medical InternationalZJYL, 2025 |
|---|---|---|
| Revenue | $19.5m | $20.7m |
| Revenue growth | 36.7% | -12.0% |
| Net income | −$3.2m | $1.2m |
| Operating margin | — | — |
| Net margin | -16.3% | 5.8% |
| Return on equity | -84.6% | 4.1% |
| Free cash flow | −$4.1m | −$3.7m |
| Cash | $2.4m | $7.5m |
| Total debt | $222,000 | $18.8m |
| Debt to equity | — | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 9 | — |
| Market value | $5.5m | $412m |
| Price vs our value range | — | — |
| Moat score | 26 (Weak) | — |
| Insider trades, 12 months | 0 buys, 0 sales | 0 buys, 0 sales |